{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:42:49Z","timestamp":1789846969885,"version":"4.0.1"},"reference-count":128,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Current treatment for invasive fungal diseases is limited to three classes of antifungal drugs: azoles, polyenes, and echinocandins. The most recently introduced antifungal class, the echinocandins, was first approved nearly 30 years ago. The limited antifungal drug portfolio is rapidly losing its clinical utility due to the inexorable rise in the incidence of invasive fungal infections and the emergence of multidrug resistant (MDR) fungal pathogens. New antifungal therapeutic agents and novel approaches are desperately needed. Here, we detail attempts to exploit the antifungal and immunoregulatory properties of host defense peptides (HDPs) in the design and evaluation of new antifungal therapeutics and discuss historical limitations and recent advances in this quest.<\/jats:p>","DOI":"10.3390\/jof6040241","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T08:59:28Z","timestamp":1603443568000},"page":"241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Host Defense Peptides as Templates for Antifungal Drug Development"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6078-3439","authenticated-orcid":false,"given":"Virginia","family":"Basso","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat Q.","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA"},{"name":"Oryn Therapeutics, Vacaville, CA 95688, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-5779","authenticated-orcid":false,"given":"Andr\u00e9 J.","family":"Ouellette","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA"},{"name":"Norris Comprehensive Cancer Center of the University of Southern California, Los Angeles, CA 90089, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-4739","authenticated-orcid":false,"given":"Michael E.","family":"Selsted","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA"},{"name":"Oryn Therapeutics, Vacaville, CA 95688, USA"},{"name":"Norris Comprehensive Cancer Center of the University of Southern California, Los Angeles, CA 90089, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: A persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pianalto, K.M., and Alspaugh, J.A. (2016). New Horizons in Antifungal Therapy. J. Fungi, 2.","DOI":"10.3390\/jof2040026"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Robbins, N., Wright, G.D., and Cowen, L.E. (2016). Antifungal Drugs: The Current Armamentarium and Development of New Agents. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","article-title":"Amphotericin B nephrotoxicity","volume":"49","author":"Deray","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","article-title":"Comparison of echinocandin antifungals","volume":"3","author":"Eschenauer","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Basso, V., Garcia, A., Tran, D.Q., Schaal, J.B., Tran, P., Ngole, D., Aqeel, Y., Tongaonkar, P., Ouellette, A.J., and Selsted, M.E. (2018). Fungicidal Potency and Mechanisms of theta-Defensins against Multidrug-Resistant Candida Species. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.00111-18"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"47","author":"Walker","year":"2010","journal-title":"Fungal Genet. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14787210.2017.1364992","article-title":"Candida auris: A worrisome, globally emerging pathogen","volume":"15","author":"Navalkele","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Spivak, E.S., and Hanson, K.E. (2018). Candida auris: An Emerging Fungal Pathogen. J. Clin. Microbiol., 56.","DOI":"10.1128\/JCM.01588-17"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Clark, C., and Drummond, R.A. (2019). The Hidden Cost of Modern Medical Interventions: How Medical Advances Have Shaped the Prevalence of Human Fungal Disease. Pathogens, 8.","DOI":"10.3390\/pathogens8020045"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of Direct Healthcare Costs of Fungal Diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc-2016-0035","article-title":"Natural and synthetic peptides with antifungal activity","volume":"8","author":"Ciociola","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"BR Da Silva, L., Taborda, C.P., and Nosanchuk, J.D. (2020). Advances in Fungal Peptide Vaccines. J. Fungi, 6.","DOI":"10.3390\/jof6030119"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.176.4.2455","article-title":"Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37","volume":"176","author":"Mookherjee","year":"2006","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.iy.13.040195.000425","article-title":"Peptide antibiotics and their role in innate immunity","volume":"13","author":"Boman","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/S0021-9258(18)89110-4","article-title":"Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils","volume":"260","author":"Selsted","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/iai.45.1.150-154.1984","article-title":"Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes","volume":"45","author":"Selsted","year":"1984","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1218831","article-title":"Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets","volume":"337","author":"Chu","year":"2012","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","article-title":"The dorsoventral regulatory gene cassette spatzle\/Toll\/cactus controls the potent antifungal response in Drosophila adults","volume":"86","author":"Lemaitre","year":"1996","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/35106587","article-title":"Innate antimicrobial peptide protects the skin from invasive bacterial infection","volume":"414","author":"Nizet","year":"2001","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature01520","article-title":"Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin","volume":"422","author":"Salzman","year":"2003","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.286.5437.113","article-title":"Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense","volume":"286","author":"Wilson","year":"1999","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1208\/s12248-011-9252-2","article-title":"Analyzing the cryptome: Uncovering secret sequences","volume":"13","author":"Samir","year":"2011","journal-title":"AAPS J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1211\/0022357022971","article-title":"Histatins: Antimicrobial peptides with therapeutic potential","volume":"56","author":"Kavanagh","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/EC.00095-14","article-title":"How does it kill?: Understanding the candidacidal mechanism of salivary histatin 5","volume":"13","author":"Puri","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/08927010903501908","article-title":"Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane","volume":"26","author":"Devreese","year":"2010","journal-title":"Biofouling"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.archoralbio.2009.01.016","article-title":"Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine","volume":"54","author":"Pusateri","year":"2009","journal-title":"Arch. Oral Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/AAC.00411-06","article-title":"Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: Role of endocytosis and treatment implications","volume":"50","author":"Zhu","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/eji.200939275","article-title":"The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils","volume":"40","author":"Alalwani","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.49.7.2845-2850.2005","article-title":"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37","volume":"49","author":"Ciornei","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BJ20042099","article-title":"Candidacidal effects of two antimicrobial peptides: Histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane","volume":"388","author":"Bolscher","year":"2005","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1574-695X.2009.00571.x","article-title":"Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli","volume":"56","author":"Filewod","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_41","first-page":"3760","article-title":"The role of the multifunctional peptide LL-37 in host defense","volume":"13","author":"Agerberth","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2019.00283","article-title":"LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.4049\/jimmunol.176.5.3044","article-title":"An antimicrobial cathelicidin peptide, human CAP18\/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7","volume":"176","author":"Nagaoka","year":"2006","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.175.3.1776","article-title":"The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes","volume":"175","author":"Niyonsaba","year":"2005","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbrc.2013.11.074","article-title":"The human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary disease","volume":"443","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbagen.2012.02.015","article-title":"Characterization of dual effects induced by antimicrobial peptides: Regulated cell death or membrane disruption","volume":"1820","author":"Martins","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0005-2736(95)00087-J","article-title":"Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity","volume":"1237","author":"Ahmad","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_48","first-page":"257","article-title":"Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells","volume":"11","author":"Chaly","year":"2000","journal-title":"Eur. Cytokine Netw."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2005-06-2314","article-title":"Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway","volume":"107","author":"Khine","year":"2006","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1073\/pnas.96.2.651","article-title":"Mechanisms for induction of acquired host immunity by neutrophil peptide defensins","volume":"96","author":"Lillard","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jcp.21279","article-title":"Differential signaling mechanisms of HNP-induced IL-8 production in human lung epithelial cells and monocytes","volume":"214","author":"Syeda","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1075565","article-title":"Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2","volume":"298","author":"Biragyn","year":"2002","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1189\/jlb.0111004","article-title":"Human \u03b2-defensin-2 enhances IFN-\u03b3 and IL-10 production and suppresses IL-17 production in T cells","volume":"89","author":"Kanda","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5700599","article-title":"Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines","volume":"127","author":"Niyonsaba","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.00478-06","article-title":"Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption","volume":"51","author":"Vylkova","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Freitas, C.G., Lima, S.M.F., Freire, M.S., Cantuaria, A.P.C., Junior, N.G.O., Santos, T.S., Folha, J.S., Ribeiro, S.M., Dias, S.C., and Rezende, T.M.B. (2017). An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02518-16"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.chembiol.2010.07.007","article-title":"Structural studies of a peptide with immune modulating and direct antimicrobial activity","volume":"17","author":"Wieczorek","year":"2010","journal-title":"Chem. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/522427","article-title":"Human lactoferrin-derived peptide\u2019s antifungal activities against disseminated Candida albicans infection","volume":"196","author":"Lupetti","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/AAC.44.12.3257-3263.2000","article-title":"Candidacidal activities of human lactoferrin peptides derived from the N terminus","volume":"44","author":"Lupetti","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"16905","DOI":"10.1038\/s41598-019-53402-z","article-title":"Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms","volume":"9","author":"Basso","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1074\/jbc.RA117.000793","article-title":"Macrocyclic theta-defensins suppress tumor necrosis factor-alpha (TNF-alpha) shedding by inhibition of TNF-alpha-converting enzyme","volume":"293","author":"Schaal","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Schaal, J.B., Tran, D., Tran, P., Osapay, G., Trinh, K., Roberts, K.D., Brasky, K.M., Tongaonkar, P., Ouellette, A.J., and Selsted, M.E. (2012). Rhesus macaque theta defensins suppress inflammatory cytokines and enhance survival in mouse models of bacteremic sepsis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051337"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Schaal, J.B., Tran, D.Q., Subramanian, A., Patel, R., Laragione, T., Roberts, K.D., Trinh, K., Tongaonkar, P., Tran, P.A., and Minond, D. (2017). Suppression and resolution of autoimmune arthritis by rhesus theta-defensin-1, an immunomodulatory macrocyclic peptide. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187868"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1189\/jlb.3A0315-102R","article-title":"Rhesus macaque theta-defensin RTD-1 inhibits proinflammatory cytokine secretion and gene expression by inhibiting the activation of NF-kappaB and MAPK pathways","volume":"98","author":"Tongaonkar","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1128\/JVI.01363-09","article-title":"Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease","volume":"83","author":"Meyerholz","year":"2009","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jiu556","article-title":"CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitis","volume":"211","author":"Ramachandran","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jit104","article-title":"A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes","volume":"207","author":"Ramachandran","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1517\/14712598.2015.1033393","article-title":"Historical review of thymosin alpha 1 in infectious diseases","volume":"15","author":"Camerini","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.vh.2016.04.003","article-title":"Immune Modulation with Thymosin Alpha 1 Treatment","volume":"102","author":"King","year":"2016","journal-title":"Vitam. Horm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14712598.2018.1484104","article-title":"Thymosin alpha 1 treatment for patients with sepsis","volume":"18","author":"Pei","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41598-017-04462-6","article-title":"Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism","volume":"7","author":"Menzel","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1128\/AAC.02649-13","article-title":"Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasis","volume":"58","author":"Ryan","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1189\/jlb.0403147","article-title":"Cathelicidins, multifunctional peptides of the innate immunity","volume":"75","author":"Zanetti","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/rr25","article-title":"Epithelial antimicrobial peptides in host defense against infection","volume":"1","author":"Bals","year":"2000","journal-title":"Respir. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V96.9.3086","article-title":"The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations","volume":"96","author":"Agerberth","year":"2000","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1432-1033.1996.0325z.x","article-title":"The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes","volume":"238","author":"Gudmundsson","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: The role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1128\/AEM.01560-10","article-title":"Screening for antifungal peptides and their modes of action in Aspergillus nidulans","volume":"76","author":"Mania","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Tsai, P.W., Yang, C.Y., Chang, H.T., and Lan, C.Y. (2011). Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017755"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1016\/S0021-9258(18)42830-X","article-title":"Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils","volume":"267","author":"Selsted","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-3011.1995.tb01055.x","article-title":"Synthesis and characterization of indolicidin, a tryptophan-rich antimicrobial peptide from bovine neutrophils","volume":"45","author":"Tang","year":"1995","journal-title":"Int. J. Pept. Protein Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2174\/138161207782110363","article-title":"A pocket guide to explorations of the defensin field","volume":"13","author":"Selsted","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni1206","article-title":"Mammalian defensins in the antimicrobial immune response","volume":"6","author":"Selsted","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1172\/JCI113527","article-title":"Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations","volume":"81","author":"Lehrer","year":"1988","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.37.12.2628","article-title":"Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro","volume":"37","author":"Alcouloumre","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/infdis\/151.5.890","article-title":"In vitro effect of phagocyte cationic peptides on Coccidioides immitis","volume":"151","author":"Segal","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/infdis\/154.3.483","article-title":"In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages","volume":"154","author":"Levitz","year":"1986","journal-title":"J. Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1189\/jlb.0708412","article-title":"Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91","volume":"86","author":"Presicce","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_90","first-page":"L888","article-title":"Effect of defensins on interleukin-8 synthesis in airway epithelial cells","volume":"272","author":"Daha","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0924-8579(03)00180-8","article-title":"Antimicrobial peptides in animals and their role in host defences","volume":"22","author":"Brogden","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/intimm\/12.5.691","article-title":"Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens","volume":"12","author":"Tani","year":"2000","journal-title":"Int. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.68.1.9","article-title":"Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells","volume":"68","author":"Yang","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4049\/jimmunol.179.6.3958","article-title":"Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family","volume":"179","author":"Grigat","year":"2007","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1073\/pnas.88.9.3952","article-title":"Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: Peptide isolation and cloning of a cDNA","volume":"88","author":"Diamond","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1016\/S0021-9258(18)53298-1","article-title":"Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils","volume":"268","author":"Selsted","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrmicro976","article-title":"Primate defensins","volume":"2","author":"Lehrer","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.3389\/fimmu.2018.03072","article-title":"beta-Defensins: Farming the Microbiome for Homeostasis and Health","volume":"9","author":"Meade","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1096\/fj.00-0865fje","article-title":"Human beta-defensin 4: A novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity","volume":"15","author":"Garcia","year":"2001","journal-title":"FASEB J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1073\/pnas.93.10.5156","article-title":"Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells","volume":"93","author":"Diamond","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-1119(00)00569-2","article-title":"Discovery of new human beta-defensins using a genomics-based approach","volume":"263","author":"Jia","year":"2001","journal-title":"Gene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/iai.64.5.1565-1568.1996","article-title":"Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha","volume":"64","author":"Russell","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1357-2725(99)00013-8","article-title":"Human beta-defensin-2","volume":"31","author":"Schroder","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1073\/pnas.95.25.14961","article-title":"Production of beta-defensins by human airway epithelia","volume":"95","author":"Singh","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.0603508103","article-title":"Inducing endogenous antimicrobial peptides to battle infections","volume":"103","author":"Zasloff","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/IAI.67.6.3121-3127.1999","article-title":"Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations","volume":"67","author":"Shi","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1172\/JCI1861","article-title":"Human beta-defensin-1: An antimicrobial peptide of urogenital tissues","volume":"101","author":"Valore","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/JCM.42.3.1024-1029.2004","article-title":"Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms","volume":"42","author":"Joly","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.00470-08","article-title":"Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3","volume":"53","author":"Krishnakumari","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/eji.200940041","article-title":"Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo","volume":"40","author":"Semple","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fchem.2019.00043","article-title":"Reassessing the Host Defense Peptide Landscape","volume":"7","author":"Haney","year":"2019","journal-title":"Front. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Lee, A.C., Harris, J.L., Khanna, K.K., and Hong, J.H. (2019). A Comprehensive Review on Current Advances in Peptide Drug Development and Design. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102383"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.it.2014.07.004","article-title":"Host defense peptides: Front-line immunomodulators","volume":"35","author":"Mansour","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"27014","DOI":"10.1074\/jbc.R112.346098","article-title":"theta-Defensins: Cyclic peptides with endless potential","volume":"287","author":"Lehrer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.286.5439.498","article-title":"A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins","volume":"286","author":"Tang","year":"1999","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1189\/jlb.0910535","article-title":"Rhesus macaque theta-defensin isoforms: Expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities","volume":"89","author":"Tongaonkar","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1128\/IAI.01100-08","article-title":"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes","volume":"76","author":"Garcia","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/AAC.01090-07","article-title":"Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins","volume":"52","author":"Tran","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/dkv301","article-title":"Rhesus theta-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa","volume":"71","author":"Beringer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1167\/iovs.07-0302","article-title":"Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis","volume":"48","author":"Brandt","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Seidel, A., Ye, Y., de Armas, L.R., Soto, M., Yarosh, W., Marcsisin, R.A., Tran, D., Selsted, M.E., and Camerini, D. (2010). Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009737"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/JVI.78.10.5147-5156.2004","article-title":"Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry","volume":"78","author":"Yasin","year":"2004","journal-title":"J. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Jayne, J.G., Bensman, T.J., Schaal, J.B., Park, A.Y.J., Kimura, E., Tran, D., Selsted, M.E., and Beringer, P.M. (2017). Rhesus Theta (theta)-Defensin-1 Attenuates Endotoxin-Induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment. Am. J. Respir. Cell Mol. Biol.","DOI":"10.1165\/rcmb.2016-0428OC"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Bensman, T.J., Jayne, J.G., Sun, M., Kimura, E., Meinert, J., Wang, J.C., Schaal, J.B., Tran, D., Rao, A.P., and Akbari, O. (2017). Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.00154-17"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/1568026616666160713130452","article-title":"Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications","volume":"17","author":"Scott","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Chowdhury, M.H., Ryan, L.K., Cherabuddi, K., Freeman, K.B., Weaver, D.G., Pelletier, J.C., Scott, R.W., and Diamond, G. (2018). Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis. J. Fungi, 4.","DOI":"10.3390\/jof4010030"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/AAC.00208-07","article-title":"Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens","volume":"51","author":"Beckloff","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/4\/241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:26:39Z","timestamp":1760178399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/4\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":128,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["jof6040241"],"URL":"https:\/\/doi.org\/10.3390\/jof6040241","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}